Cherradi, Sara
Roux, Salomé
Dupuy, Marie
Tabone-Eglinger, Séverine
Tuaillon, Edouard
Ziol, Marianne
Assenat, Eric
Duong, Hong Tuan
Funding for this research was provided by:
France 2030 Plan “Projets d’Innovation” (DOS0222542/00 & DOS0222543/00)
Programme d’investissements d’avenir (BFTE DOS0178148/00)
Article History
Received: 10 October 2024
Accepted: 23 December 2024
First Online: 7 January 2025
Declarations
:
: S.C., S.R., and H.T.D. are employees of PredictCan Biotechnologies SAS. S.C. and H.T.D. are founders of PredictCan Biotechnologies SAS. The other authors have no competing interests.
: The research protocol was conducted under French legal guidelines and fulfilled the requirements of the local institutional ethics committee. The study was approved by the “Direction Générale de la recherche et de l’innovation” (CODECOH, n°DC-2021-4779). This project does not involve the human person according to the legislation (article L1121-1 du code de la santé publique).